REPORT ID 4746

United States Anticoagulants Market Report 2017

Publish Date
19-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the United States Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Anticoagulants market competition by top manufacturers/players, with Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi
    Bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Genentech (Roche)
    AstraZeneca
    Bristol-Myers Squibb
    Aspen
    Lilly
    Otsuka
    Pfizer
    Daiichi Sankyo
    The Medicines Company

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Platelet aggregation inhibitors (PAI)
    Low-molecular-weight Heparin (LMWH)
    Direct thrombin inhibitor (DTI)
    Direct factor Xa inhibitors (DFXa)
    Vitamin K antagonists (VKA)
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    VTE
    ACS/MI
    AF
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Anticoagulants Market Report 2017
1 Anticoagulants Overview
    1.1 Product Overview and Scope of Anticoagulants
    1.2 Classification of Anticoagulants by Product Category
        1.2.1 United States Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Platelet aggregation inhibitors (PAI)
        1.2.4 Low-molecular-weight Heparin (LMWH)
        1.2.5 Direct thrombin inhibitor (DTI)
        1.2.6 Direct factor Xa inhibitors (DFXa)
        1.2.7 Vitamin K antagonists (VKA)
        1.2.8 Others
    1.3 United States Anticoagulants Market by Application/End Users
        1.3.1 United States Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Other
    1.4 United States Anticoagulants Market by Region
        1.4.1 United States Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Anticoagulants Status and Prospect (2012-2022)
        1.4.3 Southwest Anticoagulants Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Anticoagulants Status and Prospect (2012-2022)
        1.4.5 New England Anticoagulants Status and Prospect (2012-2022)
        1.4.6 The South Anticoagulants Status and Prospect (2012-2022)
        1.4.7 The Midwest Anticoagulants Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Anticoagulants (2012-2022)
        1.5.1 United States Anticoagulants Sales and Growth Rate (2012-2022)
        1.5.2 United States Anticoagulants Revenue and Growth Rate (2012-2022)

2 United States Anticoagulants Market Competition by Players/Suppliers
    2.1 United States Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Anticoagulants Average Price by Players/Suppliers (2012-2017)
    2.4 United States Anticoagulants Market Competitive Situation and Trends
        2.4.1 United States Anticoagulants Market Concentration Rate
        2.4.2 United States Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anticoagulants Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Anticoagulants Sales and Market Share by Region (2012-2017)
    3.2 United States Anticoagulants Revenue and Market Share by Region (2012-2017)
    3.3 United States Anticoagulants Price by Region (2012-2017)

4 United States Anticoagulants Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Anticoagulants Revenue and Market Share by Type (2012-2017)
    4.3 United States Anticoagulants Price by Type (2012-2017)
    4.4 United States Anticoagulants Sales Growth Rate by Type (2012-2017)

5 United States Anticoagulants Sales (Volume) by Application (2012-2017)
    5.1 United States Anticoagulants Sales and Market Share by Application (2012-2017)
    5.2 United States Anticoagulants Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Anticoagulants Players/Suppliers Profiles and Sales Data
    6.1 Sanofi
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anticoagulants Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bayer
        6.2.2 Anticoagulants Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim
        6.3.2 Anticoagulants Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Johnson & Johnson
        6.4.2 Anticoagulants Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Genentech (Roche)
        6.5.2 Anticoagulants Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.2 Anticoagulants Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bristol-Myers Squibb
        6.7.2 Anticoagulants Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Aspen
        6.8.2 Anticoagulants Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Lilly
        6.9.2 Anticoagulants Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Otsuka
        6.10.2 Anticoagulants Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Pfizer
    6.12 Daiichi Sankyo
    6.13 The Medicines Company

7 Anticoagulants Manufacturing Cost Analysis
    7.1 Anticoagulants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anticoagulants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anticoagulants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Anticoagulants Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Anticoagulants Sales Volume Forecast by Type (2017-2022)
    11.3 United States Anticoagulants Sales Volume Forecast by Application (2017-2022)
    11.4 United States Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer